ERYTECH Announces Abstract with Results from Eryaspase Phase 2 Trial in Acute Lymphoblastic Leukemia Selected for Oral Presentation at the American Society of Hematology 2020 Annual Meeting

NEXT STORY
Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update
PREV STORY
Novartis Cosentyx® shows early synovitis reduction in patients with psoriatic arthritis in first-of-its-kind study
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Apricus Biosciences Provides Corporate Update and First Quarter 2017 Financial Results

Vitaros U.S. NDA Re-Submission Remains on Track for Third Quarter 2017 Vitaros Drug-Device Human ...

author_avatar
NASDAQ Market News

European Commission Approves JEMPERLI (dostarlimab), the First Anti-PD-1 Therapy Approved for Recurrent or Advanced dMMR/MSI-H Endometrial Cancer in Europe

author_avatar
NASDAQ Market News

Drug of Abuse Testing Market to Witness 9.6% CAGR till 2023: P&S Market Research

NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- The drug of abuse testing market ...

author_avatar
NASDAQ Market News